From the results, it is obvious that the increase of
cholesterol molar ratio from 1:0.5:0.1 to 1:1:0.1 (non-ionic
surfactant: cholesterol: DCP) markedly reduced the efflux of
the drug from niosomal preparations (F3, F4, F11 and F12),
which is in accordance with its membrane stabilizing ability